PB2636: VAYHIT1: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VERSUS PLACEBO IN ADDITION TO FIRST-LINE CORTICOSTEROIDS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP)

Detalles Bibliográficos
Autores principales: Cooper, Nichola, Cuker, Adam, Michel, Marc, Wong, Raymond, Ghanima, Waleed, Zaja, Francesco, Barcellini, Wilma, Zhang, Fengkui, Lawniczek, Tomasz, Weill, Marine, Al-Samkari, Hanny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429351/
http://dx.doi.org/10.1097/01.HS9.0000977232.29155.a4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429351/
http://dx.doi.org/10.1097/01.HS9.0000977232.29155.a4

Ejemplares similares